Comment on: Developments in outpatient parenteral antimicrobial therapy (OPAT) for Gram-positive infections in Europe, and the potential impact of daptomycin.
Niels
N
Adriaenssens
Herman
H
Goossens
Samuel
S
Coenen
D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D001424:Bacterial Infections / Q000188:drug therapy*; D017576:Daptomycin / Q000627:therapeutic use*; D005060:Europe; D006801:Humans; D010045:Outpatients
D000900:Anti-Bacterial Agents; D017576:Daptomycin